Energy metabolism as a target for cyclobenzaprine: A drug candidate against Visceral Leishmaniasis.

MLA

Lima, Marta Lopes, et al. “Energy Metabolism as a Target for Cyclobenzaprine: A Drug Candidate against Visceral Leishmaniasis.” Bioorganic Chemistry, vol. 127, Oct. 2022, p. 106009. EBSCOhost, https://doi.org/10.1016/j.bioorg.2022.106009.

APA

Lima, M. L., Abengózar, M. A., Torres-Santos, E. C., Borborema, S. E. T., Godzien, J., López-Gonzálvez, Á., Barbas, C., Rivas, L., & Tempone, A. G. (2022). Energy metabolism as a target for cyclobenzaprine: A drug candidate against Visceral Leishmaniasis. Bioorganic Chemistry, 127, 106009. https://doi.org/10.1016/j.bioorg.2022.106009

Chicago

Lima, Marta Lopes, Maria A Abengózar, Eduardo Caio Torres-Santos, Samanta Etel Treiger Borborema, Joanna Godzien, Ángeles López-Gonzálvez, Coral Barbas, Luis Rivas, and Andre Gustavo Tempone. 2022. “Energy Metabolism as a Target for Cyclobenzaprine: A Drug Candidate against Visceral Leishmaniasis.” Bioorganic Chemistry 127 (October): 106009. doi:10.1016/j.bioorg.2022.106009.